Renewed pharma interest in GPCR biology and radioligand therapies is drawing attention to functional peptide screening ...

G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a ...

Skape Bio and researchers at the University of Washington's Institute for Protein Design (IPD) today announced a ...

G-protein-coupled receptors (GPCRs) mediate most of our physiological responses to external stimuli and are involved in many diseases. Scientists have now used computer modeling to uncover central ...

G protein-coupled receptors, or GPCRs, sit in the plasma membrane, the boundary that defines the inside and outside of a ...

Just Because a G-Protein Coupled Receptor Has Resisted Characterization Doesn’t Mean It Can’t Be Sighted—or Hunted For drug developers, G-protein coupled receptors (GPCRs) are dearly sought trophies.

About a third of all approved drugs target some kind of G protein–coupled receptor (GPCR). But designing drugs for these receptors poses difficulties because they sit in the cel ...

G protein-coupled receptors (GPCRs) are the largest family of proteins targeted by approved drugs. Some 700 approved drugs target GPCRs, with 80 percent of those treatments pursuing just six ...

Over the past 20 years, naturally occurring mutations that affect G protein-coupled receptors (GPCRs) have been identified, mainly in patients with endocrine diseases. The study of loss-of-function or ...

G protein-coupled receptors (GPCRs) are the largest class of cell surface receptors in our cells, involved in signal transmission across the cell membrane. One of the biggest questions is how a signal ...

Genes that encode G-protein-coupled receptors (GPCRs) and G proteins can have loss-of-function or gain-of-function mutations, which result in endocrine disorders Loss-of-function mutations in GPCRs ...